This paper describes the diagnosis and treatment of a 5-year-old Standard Schnauzer dog admitted to the clinic due to a liver failure and chronic bloody diarrhea. Based on the initial examination, no diagnosis could be made, therefore an endoscopic examination of the gastrointestinal tract was performed. The endoscopy revealed a tumor within the ostium ileocaecocolicum. Unfortunately, shortly after this procedure, a massive hemorrhage occurred, which led to the animal’s death. The necropsy confirmed the presence of the tumor. The histopathological and immunohistochemical results of the collected specimens showed a neuroendocrine tumor (NET G1) of the large intestine. In conclusion, gastrointestinal carcinoids in dogs are relatively rare and often misdiagnosed due to complex or non-specific symptomatology.
Bu makale, karaciğer yetmezliği ve kronik kanlı ishal nedeniyle kliniğe kabul edilen 5 yaşındaki bir Standart Schnauzer köpeğinde nöroendokrin tümör teşhisini açıklamaktadır. İlk muayeneye bağlı tanı konulamadığı için köpeğin gastrointestinal sisteminin endoskopik muayenesi yapıldı. Endoskopik muayenede ostium ileocaecolicum içerisinde bir tümöre rastlandı. Ne yazık ki, bu işlemden kısa bir süre sonra, hayvanın ölümüne yol açan büyük bir kanama meydana geldi. Otopside tümörün varlığı doğrulandı. Alınan örneklerin histopatolojik ve immünohistokimyasal analizi sonucu, kalın bağırsakta bir nöroendokrin tümör (NET G1) belirlendi. Sonuç olarak, köpeklerde gastrointestinal karsinoidler nispeten nadirdir ve karmaşık veya spesifik olmayan semptomatolojisi nedeniyle sıklıkla yanlış teşhis edilirler.
___
1. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A: Gastroenteropancreatic neuroendocrine tumors. Lancet Oncol, 9, 61-72, 2008. DOI: 10.1016/ S1470-2045(07)70410-2
2. Kuwata K, Shibutani M, Kemmochi Y, Taniai E, Morita R, Ogawa B, Mitsumori K: A neuroendocrine carcinoma of undetermined origin in a dog. J Toxicol Pathol, 23 (3): 151-155, 2010. DOI: 10.1293/tox.23.151
3. Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC: Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol, 3 (10): 1335-1342,2017. DOI: 10.1001/jamaoncol.2017.0589
4. Head KW, Else RW, Dubielzig RR: Tumors of the alimentary tract. In, Meuten DJ (Ed): Tumors in Domestic Animals. 4th ed., 401-481, Iowa State Press, Ames, IA, 2002.
5. Schott M, Klöppel G, Raffel A, Saleh A, Knoefel WT, Scherbaum WA: Neuroendocrine neoplasms of the gastrointestinal tract. Dtsch Arztebl Int, 108 (18): 305-312, 2011. DOI: 10.3238/arztebl.2011.0305
6. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Oberg K, Reubi JC, Nilsson O, Delle Fave G, Ruszniewski P, Ahlman H, Wiedenmann B: Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours.Neuroendocrinology, 80, 394-424, 2004. DOI: 10.1159/000085237
7. Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G: Risk factors for neuroendocrine neoplasms: A systematic review and meta-analysis. Ann Oncol, 27, 68-81, 2016. DOI: 10.1093/annonc/mdv505
8. Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, Díaz-Pérez JA, Martínez Del Prado MP, Alonso Orduña V, Sevilla-García I, VillabonaArtero C, Beguiristain-Gómez A, Llanos-Muñoz M, Marazuela M, Alvarez-Escola C, Castellano D, Vilar E, Jiménez-Fonseca P, Teulé A, Sastre-Valera J, Benavent-Viñuelas M, Monleon A, Salazar R: Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumours (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE). Ann Oncol, 21 (9): 1794-1803, 2010. DOI: 10.1093/annonc/mdq022
9. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA: The 2019 WHO classification of tumours of the digestive system. Histopathology, 76 (2): 182-188, 2020. DOI: 10.1111/his.13975